Announced
Completed
SLAYBACK PHARMA LLC / KKR & CO / Acquisition / Private
Synopsis
Equity investment by KKR in Slayback Pharma, a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite